Paradigm Biocapital Advisors’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3M | Buy |
|
|||||
|
2025
Q1 | $28.2M | Buy |
|
|||||
|
2024
Q4 | $34.9M | Sell |
|
|||||
|
2024
Q3 | $65.9M | Sell |
|
|||||
|
2024
Q2 | $37.7M | Sell |
|
|||||
|
2024
Q1 | $88.1M | Buy |
|
|||||
|
2023
Q4 | $104M | Buy |
|
|||||
|
2023
Q3 | $56.5M | Buy |
|
|||||
|
2023
Q2 | $57.5M | Buy |
|
|||||
|
2023
Q1 | $53.1M | Buy |
|
|||||
|
2022
Q4 | $51.2M | Buy |
|
|||||
|
2022
Q3 | $33.6M | Buy |
|
|||||
|
2022
Q2 | $15.1M | Buy |
|
|||||
|
2022
Q1 | $23.2M | Buy |
|
|||||
|
2021
Q4 | $23.9M | Buy |
|